Editorial: The use of real world data for regulatory purposes in the rare diseases setting

Front Pharmacol. 2022 Nov 24:13:1089033. doi: 10.3389/fphar.2022.1089033. eCollection 2022.

Authors

Viviana Giannuzzi¹, Violeta Stoyanova-Beninska², Virginie Hivert³

Affiliations

¹ Research Department, Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Valenzano, Italy.
² Medicines Evaluation Board, Utrecht, Netherlands.
³ European Organisation for Rare Diseases (EURORDIS), Paris, France.

No abstract available

Keywords: medicine regulation; orphan medicines; rare diseases; real world data; real world evidence.

Publication types

Editorial